Literature DB >> 18329668

Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population.

Shusuke Numata1, Shu-Ichi Ueno, Jun-Ichi Iga, Hongwei Song, Masahito Nakataki, Shin'ya Tayoshi, Satsuki Sumitani, Masahito Tomotake, Mitsuo Itakura, Akira Sano, Tetsuro Ohmori.   

Abstract

The phosphodiesterase 4B (PDE4B) gene is located at 1p31, a susceptibility region for schizophrenia (SZ). Moreover, PDE4B interacts with DISC1, which is a known genetic risk factor for SZ. Recently, it was reported that the PDE4B gene is associated with SZ in Caucasian and African American populations. In this study, case-controlled association analyses were performed in the Japanese population to determine if the PDE4B gene is implicated in SZ. Thirteen single nucleotide polymorphisms (SNPs) were analyzed in 444 schizophrenic patients and 452 control subjects. Three SNPs (rs2180335, rs910694 and rs472952) were significantly associated with SZ after applying multiple test correction (p=0.039, 0.004 and 0.028). In addition, a significant association was found between specific haplotypes (rs2180335 and rs910694) and SZ (permutation p=0.001). Our result suggests that variations at the PDE4B locus may play a significant role in the etiology of SZ in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329668     DOI: 10.1016/j.jpsychires.2008.01.013

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  16 in total

1.  Association of PDE4B polymorphisms and schizophrenia in Northwestern Han Chinese.

Authors:  Fanglin Guan; Chen Zhang; Shuguang Wei; Hongbo Zhang; Xiaomin Gong; Jiali Feng; Chengge Gao; Rong Su; Huanming Yang; Shengbin Li
Journal:  Hum Genet       Date:  2011-12-11       Impact factor: 4.132

2.  Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex.

Authors:  Mahomi Kuroiwa; Gretchen L Snyder; Takahide Shuto; Atsuo Fukuda; Yuchio Yanagawa; David R Benavides; Angus C Nairn; James A Bibb; Paul Greengard; Akinori Nishi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  Elevated DISC1 transcript levels in PBMCs during acute psychosis in patients with schizophrenia.

Authors:  Ann Olincy; Robert House; Bifeng Gao; Peter Recksiek; Tzu Lip Phang; Bernadette Sullivan; Jeff P Hollis; Janet Hopkins; Ted Shade; Michael G Edwards; Ruby Vianzon; Cory Griffiths; John Ceilley; Roger W Helfrich; Jonathan Ritvo; Erica Weis; David Weiss; Judith Gault
Journal:  Transl Biomed       Date:  2011

Review 4.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 5.  PDE4 as a target for cognition enhancement.

Authors:  Wito Richter; Frank S Menniti; Han-Ting Zhang; Marco Conti
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

6.  Genetic variation in phosphodiesterase (PDE) 7B in chronic lymphocytic leukemia: overview of genetic variants of cyclic nucleotide PDEs in human disease.

Authors:  Ana M Peiró; Chih-Min Tang; Fiona Murray; Lingzhi Zhang; Loren M Brown; Daisy Chou; Laura Rassenti; Thomas J Kipps; Thomas A Kipps; Paul A Insel
Journal:  J Hum Genet       Date:  2011-07-28       Impact factor: 3.172

Review 7.  Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Authors:  D H R Blackwood; T Thiagarajah; P Malloy; B S Pickard; W J Muir
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

8.  Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses.

Authors:  Liisa Tomppo; William Hennah; Päivi Lahermo; Anu Loukola; Annamari Tuulio-Henriksson; Jaana Suvisaari; Timo Partonen; Jesper Ekelund; Jouko Lönnqvist; Leena Peltonen
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

9.  Variants in regulatory elements of PDE4D associate with major mental illness in the Finnish population.

Authors:  Vishal Sinha; Liisa Ukkola-Vuoti; Alfredo Ortega-Alonso; Minna Torniainen-Holm; Sebastian Therman; Annamari Tuulio-Henriksson; Pekka Jylhä; Jaakko Kaprio; Iiris Hovatta; Erkki Isometsä; Tyrone D Cannon; Jouko Lönnqvist; Tiina Paunio; Jaana Suvisaari; William Hennah
Journal:  Mol Psychiatry       Date:  2019-05-28       Impact factor: 15.992

Review 10.  Evaluating the links between schizophrenia and sleep and circadian rhythm disruption.

Authors:  David Pritchett; Katharina Wulff; Peter L Oliver; David M Bannerman; Kay E Davies; Paul J Harrison; Stuart N Peirson; Russell G Foster
Journal:  J Neural Transm (Vienna)       Date:  2012-05-10       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.